alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CS 316158-A 03/30/2020

Coronavirus Disease 2019 (COVID-19)

Keeping Patients on Dialysis Safe

What is COVID-19?

COVID-19 is a respiratory illness that can spread from person to 

person, similar to influenza.

Take Everyday Precautions 

• Wash your hands often with soap and water for at least 20 seconds or use hand sanitizer

with at least 60% alcohol.

• Avoid touching your face.

• Avoid close contact with people who are sick.

• Avoid crowds and keep at least six feet of space between yourself

and others if COVID-19 is spreading in your community. 

• When you cough or sneeze, cover your mouth and nose with a

tissue or use the inside of your elbow. 

» Throw used tissues in the trash and immediately clean your hands.

• Routinely clean and disinfect surfaces you often touch, such as cell

phones, computers, countertops, handles, and light switches. 

Preparing the Facility 

You may see changes as the dialysis facility prepares to keep you safe during treatment.

This may include:

• Signs with special instructions for patients with symptoms of COVID-19.

• Additional education about hand hygiene and cough etiquette. 

• Additional space in waiting rooms for ill patients to sit separated

from others. 

• A change in patient chair locations, treatment times, or days. 

• A change in the gowns, facemasks, and eye protection that the

staff wear or that you are asked to wear. 
cdc.gov/coronavirus

Monitoring Symptoms 

Symptoms of COVID-19 can range from mild symptoms to severe illness. 

COVID-19 symptoms include:

• Fever

• Cough

• Shortness of breath

If you feel sick or think you may have been exposed to COVID-19, call your

facility right away to let them know. This allows the facility to plan for

your arrival or direct you to the hospital. 

Always inform staff of fever or respiratory symptoms before entering

the treatment area.

If you are on dialysis, you should NOT postpone your treatments.

COVID-19 in the Community

If COVID-19 is spreading in your community:

• Take extra measures to put distance between yourself

and other people. 

• Talk with your family and caregivers to create a plan for if you get sick.

• Know contact information for your dialysis facility and care providers. 

• Make sure you have access to several weeks of medications and

supplies in case you need to stay home.

 Speak Up: Questions for Staff

Don’t be afraid to use your voice and ask questions such as:

• How is the facility preparing for COVID-19?

• Will there be any changes that may affect my treatment?

• What can I do to protect myself and others? 

Everyone has a role to play in staying healthy. Help protect yourself and your community 

from getting and spreading respiratory illnesses like COVID-19 by following CDC guidance.

www.cdc.gov/coronavirus/2019-ncov/community
Exhibit32



CERTIFICATION
 OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
 SARBANES-OXLEY ACT OF 2002



In
 connection with the report on Form 10-Q ofASP Ventures
 Corp. for the quarterly period ended March 31, 2008 as
 filed with the Securities and Exchange Commission on the date hereof(Report), I,Nora
 Coccaro, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906
 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

| | (1) | This Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ----------------------------------------------------------------------------------------------------------------------

| | (2) | The information contained in this Report fairly represents, in all material respects, the financial condition of the registrant at the end of the period covered by this Report and results of operations of the registrant for the period covered by this Report.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Date:
 May14, 2008

/s/
 Nora Coccaro

Nora
 Coccaro

Chief
 Executive Officer and Chief Financial Officer



This
 certification accompanies this Report pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent
 required by the Sarbanes-Oxley Act of 2002, be deemed filed by the registrant for the purposes of §18 of the Securities Exchange
 Act of 1934, as amended. This certification shall not be incorporated by reference into any filing under the Securities Act of 1933,
 as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of this Report), irrespective
 of any general incorporation language contained in such filing. A signed original of this written statement required by
 §906 has been provided to the registrant and will be retained by the registrant and furnished to the Securities and Exchange
 Commission or its staff upon request.



26
§ 115.273 Reporting to residents. ( a ) Following an investigation into a resident's allegation of sexual abuse suffered in an agency facility, the agency shall inform the resident as to whether the allegation has been determined to be substantiated, unsubstantiated, or unfounded.
( b ) If the agency did not conduct the investigation, it shall request the relevant information from the investigative agency in order to inform the resident.
( c ) Following a resident's allegation that a staff member has committed sexual abuse against the resident, the agency shall subsequently inform the resident (unless the agency has determined that the allegation is unfounded) whenever: ( 1 ) The staff member is no longer posted within the resident's unit;
( 2 ) The staff member is no longer employed at the facility;
( 3 ) The agency learns that the staff member has been indicted on a charge related to sexual abuse within the facility; or
( 4 ) The agency learns that the staff member has been convicted on a charge related to sexual abuse within the facility.
( d ) Following a resident's allegation that he or she has been sexually abused by another resident, the agency shall subsequently inform the alleged victim whenever: ( 1 ) The agency learns that the alleged abuser has been indicted on a charge related to sexual abuse within the facility; or
( 2 ) The agency learns that the alleged abuser has been convicted on a charge related to sexual abuse within the facility.
( e ) All such notifications or attempted notifications shall be documented.
( f ) An agency's obligation to report under this standard shall terminate if the resident is released from the agency's custody.
# Appendix 2 Figure A2-1

# Appendix 2 Table A2-1

# Appendix 2 Table A2-2

# Appendix 2 Table A2-3

# image1.tiff
§ 115.164 Staff first responder duties. ( a ) Upon learning of an allegation that a detainee was sexually abused, the first law enforcement staff member to respond to the report shall be required to: ( 1 ) Separate the alleged victim and abuser;
( 2 ) Preserve and protect any crime scene until appropriate steps can be taken to collect any evidence;
( 3 ) If the abuse occurred within a time period that still allows for the collection of physical evidence, request that the alleged victim not take any actions that could destroy physical evidence, including, as appropriate, washing, brushing teeth, changing clothes, urinating, defecating, smoking, drinking, or eating; and
( 4 ) If the abuse occurred within a time period that still allows for the collection of physical evidence, ensure that the alleged abuser does not take any actions that could destroy physical evidence, including, as appropriate, washing, brushing teeth, changing clothes, urinating, defecating, smoking, drinking, or eating.
( b ) If the first staff responder is not a law enforcement staff member, the responder shall be required to request that the alleged victim not take any actions that could destroy physical evidence and then notify law enforcement staff.
Rule 13a-14(a)/15d-14(a) Certification of CEO                                                                     	EXHIBIT NO. 99.4

 

CERTIFICATION
-  Home 

# In This Section

                      -  Learn About the Seaway 
                      -  Interactive Shipping Map and Shipping Schedule 
                      -  Videos about the Seaway 
                      -  Visitor Center 

## Contact the GLS

Great Lakes St. Lawrence Seaway Development Corporation (GLS)Policy HeadquartersU.S. Department of Transportation
1200 New Jersey Ave, SE W62-300Washington, DC20590United States

**Email:**GLS@dot.gov**Phone:**202-366-0091****Alt Phone:**800-785-2779****Fax:**202-366-7147****Business Hours:**8:00am-5:00 pm ET, M-F

If you are deaf, hard of hearing, or have a speech disability, please dial 7-1-1 to access telecommunications relay services.

                            - GLS on Facebook
                            - GLS on Twitter
                            - GLS on Instagram
                            - Great Lakes - St. Lawrence Seaway

# Videos about the Seaway

Check out some of these unique videos capturing the unique history of the St. Lawrence Seaway, its vitality to the North American economy, and the operation of Eisenhower and Snell Locks in Massena, New York!

## The St. Lawrence Seaway - "The Eighth Sea"

Learn from Walter Cronkite as he discusses the founding, construction, and operation of the St. Lawrence Seaway!

 

Great Lakes St. Lawrence Seaway Development Corporation: Great Lakes, Great Opportunities

For more information, please visit any of the following websites: 

https://www.greatlakes-seaway.comhttps://www.facebook.com/SeawayUSDOT

 

## 25th Anniversary Promotional Video of the St. Lawrence Seaway

Video from 1984 highlighting the silver anniversary of the St. Lawrence Seaway.

 

## Georgetown University Forum on the St. Lawrence Seaway (1959)

The Georgetown University Forum offers an important discussion designed to clarify significant topics, specifically a panel discussion on the St. Lawrence Seaway and international economic affairs. The video originated in 1959.
### Part B—Powers and Duties of Secretary
§ 94.19 Importation of meat, meat byproducts, and meat food products derived from bovines from regions of negligible risk for BSE. Meat, meat byproducts, and meat food products, as defined by FSIS in 9 CFR 301.2-except that those terms as applied to bison shall have a meaning comparable to those provided in 9 CFR 301.2 with regard to cattle, and other than boneless skeletal meat that meets the conditions of § 94.18(b)(2)—may be imported from a region of negligible risk for BSE, as defined in § 92.1 of this subchapter, if the following conditions and all other applicable requirements of this part are met: ( a ) The commodities were exported from a region of negligible risk for BSE.
( b ) If BSE has been diagnosed in one or more indigenous bovines in the region of negligible risk, the commodities were derived from bovines subject to a ban on the feeding to ruminants of meat-and-bone meal or greaves derived from ruminants.
( c ) The commodities were derived from bovines that passed ante-mortem and post-mortem inspections.
( d ) The commodities are accompanied by an original certificate stating that the exporting region is classified by APHIS as a region of negligible risk for BSE and that the conditions of paragraphs (a) through (c) of this section, as applicable, have been met. The certificate must be issued and signed by a full-time salaried veterinary officer of the national government of the exporting region, or signed by a person authorized to issue such certificates by the veterinary services of the national government of the exporting region.
Note:
To be eligible to export meat, meat byproducts, and meat food products under the conditions of this section for human consumption, a region must also be one that has demonstrated to FSIS in accordance with 9 CFR 310.22 that its BSE risk status can reasonably be expected to provide the same level of protection from human exposure to the BSE agent as does prohibiting specified risk materials for use as human food in the United States.
(Approved by the Office of Management and Budget under control number 0579-0393) [78 FR 72999, Dec. 4, 2013]
August 20, 2015

Mr. Jacob A. Senior

Representative for Lockheed Martin Missiles and Fire Control

Orlando Aviation Consultants, Inc.

P.O. Box 621295

Orlando, FL 32862

Dear Mr. Senior:

This letter is to inform you that after further review of your request for exemption, in docket 

FAA-2015-1941, your request does meet part § 11.81 requirements. Please disregard the 

rejection letter that was sent on August 14, 2015. However, this information relates to docket 

FAA-2011-0741, and we have combined your requests into docket FAA-2011-0741.

If you have any questions you may call the 333 Information Line (202) 267-2999.

Sincerely,

/s/

Brittany Newton

Program Analyst, Airmen and 

 Airspace Rules Division
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF INCOME FOUND IN THE
COMPANY'S FORM 10-K FOR THE YEAR AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> CANADIAN
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<EXCHANGE-RATE>                                 0.7222
<CASH>                                             568
<SECURITIES>                                     9,875
<RECEIVABLES>                                   30,923
<ALLOWANCES>                                         0
<INVENTORY>                                     21,120
<CURRENT-ASSETS>                                66,453
<PP&E>                                         818,610
<DEPRECIATION>                                  88,296
<TOTAL-ASSETS>                                 843,386
<CURRENT-LIABILITIES>                          193,312
<BONDS>                                        250,338
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       379,040
<OTHER-SE>                                    (62,662)
<TOTAL-LIABILITY-AND-EQUITY>                   843,386
<SALES>                                        191,167
<TOTAL-REVENUES>                               191,167
<CGS>                                          160,522
<TOTAL-COSTS>                                  198,104
<OTHER-EXPENSES>                                46,294
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,535
<INCOME-PRETAX>                              (137,925)
<INCOME-TAX>                                   (4,811)
<INCOME-CONTINUING>                          (135,215)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (135,215)
<EPS-PRIMARY>                                   (0.97)<F1>
<EPS-DILUTED>                                   (0.97)<F1>
<FN>
<F1>USING US GAAP AND SFAS 128, BASIC AND DILUTED EPS ARE BOTH $(1.10).
</FN>
        

</TABLE>
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet, consolidated statement of operations and
consolidated statement of cash flows included in Quickturn's Form 10-K/A for the
period ending December 31, 1998, and is qualified in its entirety by reference
to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                          26,552
<SECURITIES>                                    13,717
<RECEIVABLES>                                   29,745
<ALLOWANCES>                                     1,840
<INVENTORY>                                      9,904
<CURRENT-ASSETS>                                86,804
<PP&E>                                          32,506
<DEPRECIATION>                                  20,973
<TOTAL-ASSETS>                                 134,628
<CURRENT-LIABILITIES>                           44,273
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            18
<OTHER-SE>                                      90,337
<TOTAL-LIABILITY-AND-EQUITY>                   134,628
<SALES>                                        104,109
<TOTAL-REVENUES>                               104,109
<CGS>                                           38,017
<TOTAL-COSTS>                                   38,017
<OTHER-EXPENSES>                                81,791
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 132
<INCOME-PRETAX>                               (12,620)
<INCOME-TAX>                                   (5,762)
<INCOME-CONTINUING>                            (6,858)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,858)
<EPS-PRIMARY>                                   (0.39)
<EPS-DILUTED>                                   (0.39)
        

</TABLE>
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Service Bancorp, Inc. (the Company) on Form 10-QSB for the quarter ended September 30, 2005 as
filed with the Securities and Exchange Commission on the date hereof (the Report), I, Dana S. Philbrook, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of
the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



This certification is provided solely pursuant to 18 U.S.C. Section 1350
and Item 601(b)(32) of Regulation S-B (Item 601(b)(32)) promulgated under the Securities Act of 1933 (the Securities Act) and the Securities Exchange Act of 1934 (the Exchange Act). In accordance with clause
(ii) of Item 601(b)(32), this certification (A) shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, and (B) shall not be deemed to be
incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.



|                        
|------------------------
|                        
|/s/    DANA S. PHILBROOK
|Dana S. Philbrook       
|Chief Financial Officer 
|                        
|November 10, 2005
EXHIBIT 32

CERTIFICATION PURSUANT
TO                              18 U.S.C. SECTION 1350,                              AS
ADOPTED PURSUANT TO                   SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report on Form 10-KSB (the Report) of Advanced
Nutraceuticals, Inc. (the Company) for the year ended September 30, 2005, each
of the undersigned Gregory Pusey, the President and Chief Executive Officer of the
Company, and Jeffrey G. McGonegal, the Senior Vice President-Finance and Chief Financial
Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the
undersigneds knowledge and belief:

(1)       
          the Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and

(2)       
          the information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.

|                                                                                                            |                                                                                                                                                                                 
|----------------------------------------------------------------------------------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Dated: January  13, 2006  
                           
                           
Dated:  January 13, 2006 | \s\ Gregory Pusey
Gregory Pusey, President and
Chief Executive Officer
 \s\ Jeffrey G. McGonegal
Jeffrey G. McGonegal, Senior Vice
President-Finance and Chief Financial Officer

*   *   *   *   *

A signed original of the written
statement required by Section 906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange Commission or its staff upon
request.

---
<PAGE>







                                                         Exhibit 10.10








Nicholas Ioli, Jr.
14 Crooked Hill
Oakland, New Jersey 07436

Dear Nick:

As we discussed, this Letter Agreement (the "Letter Agreement") will serve to
amend the Employment Agreement (the "Agreement") entered into as of November 1,
2000, by and between yourself and The Great Atlantic & Pacific Tea Company, Inc.
(the "Company"). Notwithstanding Section 10 of the Agreement which provides for
an 18 month severance benefit period (the "Severance Period"), the Company is
agreeable to reviewing, on a month-to-month basis, the possible extension of the
Severance Period to 24 months. Accordingly, at the end of the 17th month of the
Severance Period, should you not be employed, the Company will, after
considering all of the circumstances, determine if it chooses to extend the
Severance Period for an additional month. If the Company so decides to extend
the Severance Period for a 19th month, then at the end of the 18th month, should
you still not be employed, we will again review all of the circumstances, and so
on and so forth through and finally concluding at the end of the 23rd month from
the date of your termination. If at any time during the review process, should
the Company decide not to extend the Severance Period, then at such time the
process shall end.

Except as amended by this Letter Agreement, the terms of the Agreement shall
remain in full force and effect.

Sincerely,

The Great Atlantic & Pacific Tea Company, Inc.


By:   /s/Laurane Magliari
      ------------------------
      Laurane Magliari
      Senior Vice President


AGREED TO AND ACCEPTED BY:


/s/Nick Ioli, Jr. 04/03/02
--------------------------
Nick Ioli, Jr.